Myriad Genetics Newsroom

Myriad Genetics Partners With Hannah Storm To Promote Breast Cancer Risk Assessment Program

RTTNewsJan 10 09:12

Express News | Myriad Genetics Signs Agreement With Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

BreakingsJan 10 05:30

Investors in Myriad Genetics (NASDAQ:MYGN) From Five Years Ago Are Still Down 51%, Even After 4.3% Gain This Past Week

Simply Wall StJan 8 21:04

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 8 21:00

The University Of Texas MD Anderson Cancer Center And Myriad Genetics Announce A 5-Year Strategic Alliance To Accelerate The Clinical Evaluation And Development Of Myriad's Molecular Residual Disease Assay

BenzingaJan 7 21:03

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

GlobeNewswireJan 6 21:00

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Intrinsic Value Is Potentially 97% Above Its Share Price

Yahoo FinanceDec 24, 2024 18:44

Myriad Genetics' RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

GlobeNewswireDec 20, 2024 05:15

Is Myriad Genetics Stock a Smart Hold for Your Portfolio Right Now?

Zacks Dec 17, 2024 18:30

Myriad Genetics Is Maintained at Underperform by B of A Securities

Dow JonesDec 14, 2024 00:25 · Ratings

Myriad Genetics Analyst Ratings

BenzingaDec 14, 2024 00:14 · Ratings

BofA Securities Maintains Myriad Genetics(MYGN.US) With Sell Rating, Cuts Target Price to $13

Futu NewsDec 13, 2024 21:33 · Ratings

Top Premarket Decliners

MT NewswiresDec 12, 2024 20:51

Express News | Myriad Genetics Inc : Jefferies Cuts Target Price to $13 From $15

BreakingsDec 12, 2024 14:47

Myriad Genetics Engages With UnitedHealthcare on Access to GeneSight Test Following Policy Update

BarchartDec 11, 2024 17:46

Express News | Negotiations between Myriad and UnitedHealth Insurance may extend to early 2025.

BreakingsDec 11, 2024 08:12

Myriad Genetics Talks With UnitedHealthcare on Insurance Exclusion Might Extend Into 2025

WSJDec 11, 2024 08:01

Myriad Genetics: During 3Q Earnings Call Provided Estimate of 2024 Fincl Impact of UNH's Updated Medical Policy, Myriad Reaffirms Estimate >MYGN

Dow JonesDec 11, 2024 07:37

Myriad Genetics: Engaged in Dialogue With UNH Regarding Clinical Evidence Supporting Myriad's Proprietary and Clinically Differentiated Mental Health Medication Test GeneSight >MYGN

Dow JonesDec 11, 2024 07:37

Myriad Genetics: Desire Resolution Ahead of Yr-End, But Discussions May Extend Into Early 2025 >MYGN

Dow JonesDec 11, 2024 07:37